LBA Wealth Management’s Core Laboratories CLB Stock Holding History

LBA Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-140	Closed	-$20K	–	310
2014 Q3	$20K	Buy	+140	New	+$21.6K	0.01%	233

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LBA Wealth Management's CLB Position: Q4 2014 in Review

LBA Wealth Management sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 140 shares — an estimated $20K sold.

LBA Wealth Management first reported a position in CLB in Q3 2014 and held it in 1 quarter. The position peaked at $20K in Q3 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

LBA Wealth Management reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
LBA Wealth Management sold 140 Core Laboratories shares in Q4 2014, an estimated $20K.
LBA Wealth Management first reported a position in Core Laboratories in Q3 2014 and held it in 1 quarter.
LBA Wealth Management's Core Laboratories position peaked at $20K in Q3 2014.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on LBA Wealth Management's 13F filing for Q4 2014, filed 4 Feb 2015.